Abstract：Objective To investigate the association between childhood obesity and type 2 diabetes mellitus (T2DM) as well as coronary artery heart disease (CHD). Methods Genome-wide association study (GWAS) data for childhood obesity were collected from the ECG consortium, encompassing information on children aged 2 to 18 years, including 18 613 cases and 12 696 controls. GWAS data for T2DM were collected from the DIAGRAM consortium, including 242 283 cases and 1 569 734 controls. GWAS data for CHD were collected from the CARDIoGRAMplusC4D consortium, including 10 801 cases and 137 371 controls. Pleiotropic genes associated with both T2DM and CHD were analyzed using the MAGMA, PLACO and conditional false discovery rate (cFDR) methods. Mendelian randomization (MR) analysis was performed using inverse variance weighted (IVW) method, exploring the causal relationships among childhood obesity, T2DM and CHD. Heterogeneity was evaluated using Cochran's Q test, horizontal pleiotropy and exclude outliers were tested using MR-Egger regression and MR-PRESSO test. The mediating variables among the three diseases were investigated by using a mediation analysis. Results The results of MAGMA, PLACO and cFDR analyses identified 80 pleiotropic genes associated with both T2DM and CHD, primarily distributed on chromosomes 3, 17 and 19. The MR analysis revealed that childhood obesity increased the risk of T2DM (OR=1.151, 95%CI: 1.033-1.283) and CHD (OR=1.158, 95%CI: 1.068-1.255), T2DM increased the risk of CHD (OR=1.182, 95%CI: 1.139-1.227), and CHD increased the risk of T2DM (OR=1.124, 95%CI: 1.055-1.198). The MR-Egger regression analysis showed no horizontal pleiotropy, and the MR-PRESSO test did not identify any outliers (all P>0.05). Mediation analysis indicated that childhood obesity directly increased the risk of CHD (effect value=0.096, 95%CI: 0.012-0.180) and indirectly increased the risk of CHD through T2DM (effect value=0.023, 95%CI: 0.005-0.041), with the mediation effect accounting for 15.65% of the total effect. Conclusions There are potential causal associations between childhood obesity and T2DM as well as CHD, with a bidirectional causal relationship between T2DM and CHD. T2DM also plays a mediating role in the association between childhood obesity and CHD.
陈海苗, 马岩, 刘明奇, 马珊珊, 李军, 方益荣. 儿童期肥胖与2型糖尿病、冠心病的孟德尔随机化研究[J]. 预防医学, 2025, 37(3): 307-311.
CHEN Haimiao, MA Yan, LIU Mingqi, MA Shanshan, LI Jun, FANG Yirong. Association among childhood obesity, type 2 diabetes mellitus and coronary artery heart disease: a Mendelian randomization study. Preventive Medicine, 2025, 37(3): 307-311.
[1] MUNIR M,ZAKARIA Z A,NISAR H,et al.Global human obesity and global social index:relationship and clustering[J].Front Nutr,2023,10:1-11. [2] SIMMONDS M,LLEWELLYN A,OWEN C G,et al.Predicting adult obesity from childhood obesity:a systematic review and meta-analysis[J].Obes Rev,2016,17(2):95-107. [3] BENDOR C D,BARDUGO A,PINHAS-HAMIEL O,et al.Cardiovascular morbidity,diabetes and cancer risk among children and adolescents with severe obesity[J].Cardiovasc Diabetol,2020,19(1):1-14. [4] SHEN M,XIE Q Y,ZHANG R Z,et al.Metabolite-assisted models improve risk prediction of coronary heart disease in patients with diabetes[J].Front Pharmacol,2023,14:1-9. [5] SUZUKI K,HATZIKOTOULAS K,SOUTHAM L,et al.Genetic drivers of heterogeneity in type 2 diabetes pathophysiology[J].Nature,2024,627(8003):347-357. [6] NELSON C P,GOEL A,BUTTERWORTH A S,et al.Association analyses based on false discovery rate implicate new loci for coronary artery disease[J].Nat Genet,2017,49(9):1385-1391. [7] VISSCHER P M,WRAY N R,ZHANG Q,et al.10 years of GWAS discovery:biology,function,and translation[J].Am J Hum Genet,2017,101(1):5-22. [8] BRADFIELD J P,VOGELEZANG S,FELIX J F,et al.A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity[J].Hum Mol Genet,2019,28(19):3327-3338. [9] LAWLOR D A,HARBORD R M,STERNE J A C,et al.Mendelian randomization:using genes as instruments for making causal inferences in epidemiology[J].Stat Med,2008,27(8):1133-1163. [10] DE LEEUW C A,MOOIJ J M,HESKES T,et al.MAGMA:generalized gene-set analysis of GWAS data[J].PLoS Comput Biol,2015,11(4):1-19. [11] ANDREASSEN O A,DJUROVIC S,THOMPSON W K,et al.Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors[J].Am J Hum Genet,2013,92(2):197-209. [12] RAY D,CHATTERJEE N.A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between type 2 diabetes and prostate cancer[J].PLoS Genet,2020,16(12):1-25. [13] HARTWIG F P,DAVEY SMITH G,BOWDEN J.Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption[J].Int J Epidemiol,2017,46(6):1985-1998. [14] SANDERSON E,DAVEY SMITH G,WINDMEIJER F,et al.An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings[J].Int J Epidemiol,2019,48(3):713-727. [15] BJERREGAARD L G,JENSEN B W,ÄNGQUIST L,et al.Change in overweight from childhood to early adulthood and risk of type 2 diabetes[J].N Engl J Med,2018,378(26):2537-2538. [16] SINAIKO A R,DONAHUE R P,JACOBS JR D R,et al.Relation of weight and rate of increase in weight during childhood and adolescence to body size,blood pressure,fasting insulin,and lipids in young adults:the Minneapolis Children's Blood Pressure Study[J].Circulation,1999,99(11):1471-1476. [17] GENG T,SMITH C E,LI C W,et al.Childhood BMI and adult type 2 diabetes,coronary artery diseases,chronic kidney disease,and cardiometabolic traits:a Mendelian randomization analysis[J].Diabetes Care,2018,41(5):1089-1096. [18] JEPPESEN J,HANSEN T W,RASMUSSEN S,et al.Insulin resistance,the metabolic syndrome,and risk of incident cardiovascular disease:a population-based study[J].J Am Coll Cardiol,2007,49(21):2112-2119. [19] ANDREOZZI F,GASTALDELLI A,MANNINO G C,et al.Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism,insulin resistance and beta cell dysfunction[J].Atherosclerosis,2013,229(2):277-281. [20] WU H Z,BALLANTYNE C M.Metabolic inflammation and insulin resistance in obesity[J].Circ Res,2020,126(11):1549-1564. [21] WOLF R M,JAFFE A E,RODRIGUEZ S,et al.Altered adipokines in obese adolescents:a cross-sectional and longitudinal analysis across the spectrum of glycemia[J].Am J Physiol Endocrinol Metab,2021,320(6):1044-1052.
